| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017966626 |
| P356 | DOI | 10.1007/S00726-009-0437-2 |
| P3181 | OpenCitations bibliographic resource ID | 2977912 |
| P698 | PubMed publication ID | 20012548 |
| P5875 | ResearchGate publication ID | 40689980 |
| P2093 | author name string | Yang Li | |
| Hua Liu | |||
| Yan Huang | |||
| Junqi He | |||
| Li-Cui Sun | |||
| Jun-Fang Zheng | |||
| P2860 | cites work | PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling | Q24303571 |
| Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation | Q24309608 | ||
| NHE-RF, a Regulatory Cofactor for Na+-H+Exchange, Is a Common Interactor for Merlin and ERM (MERM) Proteins | Q24320465 | ||
| Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity | Q24515074 | ||
| Autocrine PDGFR signaling promotes mammary cancer metastasis | Q24545375 | ||
| EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma | Q28182609 | ||
| Human Delta1-pyrroline-5-carboxylate synthase: function and regulation | Q28275915 | ||
| The MAPK signaling cascade | Q28292599 | ||
| Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis | Q28585214 | ||
| ERK and the F-box protein betaTRCP target STAT1 for degradation | Q28590914 | ||
| Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells | Q28592252 | ||
| The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. | Q30479321 | ||
| Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1) | Q35633702 | ||
| Contact-dependent inhibition of EGFR signaling by Nf2/Merlin | Q36118464 | ||
| Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway. | Q36536571 | ||
| PDGF receptors as targets in tumor treatment | Q36786075 | ||
| PTEN: its deregulation and tumorigenesis. | Q36935178 | ||
| Roles of NHERF1/EBP50 in cancer | Q37264782 | ||
| The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface | Q37657288 | ||
| Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function | Q38304289 | ||
| Mutant rat strain lacking D-amino-acid oxidase | Q39948749 | ||
| RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo | Q39975996 | ||
| GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes | Q40012240 | ||
| Induction of apoptosis in MCF-7 and MDA-MB-231 breast cancer cells by Oligonol is mediated by Bcl-2 family regulation and MEK/ERK signaling | Q40122864 | ||
| 7,8-Dihydroxy-4-methylcoumarin induces apoptosis of human lung adenocarcinoma cells by ROS-independent mitochondrial pathway through partial inhibition of ERK/MAPK signaling | Q40136164 | ||
| Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells | Q40208196 | ||
| A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration | Q40552003 | ||
| Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24. | Q40635382 | ||
| NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer | Q45092731 | ||
| The beta1-adrenergic receptor mediates extracellular signal-regulated kinase activation via Galphas | Q46225959 | ||
| Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells | Q46439526 | ||
| The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation | Q46694931 | ||
| A complexity-based method for predicting protein subcellular location | Q51870852 | ||
| A germ line mutation in the death domain of DAPK-1 inactivates ERK-induced apoptosis | Q52576454 | ||
| Inhibition of intracellular peroxides and apoptosis of lymphocytes in lupus-prone B/W mice by dietary n-6 and n-3 lipids with calorie restriction | Q74539144 | ||
| Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway | Q79656081 | ||
| Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer | Q80530484 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| positive regulation of intrinsic apoptotic signaling pathway | Q14818096 | ||
| SLC9A3 regulator 1 | Q21112493 | ||
| P304 | page(s) | 1261-8 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | Amino Acids | Q15757015 |
| P1476 | title | EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity | |
| P478 | volume | 38 |
| Q24323184 | Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling |
| Q43106592 | Clinical significance of EBP50 overexpression assessed by quantum dot analysis in gastric cancer |
| Q36319689 | EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation |
| Q38966467 | EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway |
| Q47250144 | EBP50 suppresses the proliferation of MCF-7 human breast cancer cells via promoting Beclin-1/p62-mediated lysosomal degradation of c-Myc. |
| Q36163714 | High-Resolution 4C Reveals Rapid p53-Dependent Chromatin Reorganization of the CDKN1A Locus in Response to Stress |
| Q33932203 | Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma |
| Q26800001 | Insulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant disease |
| Q37584289 | Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma |
| Q92839076 | Mcl-1 signals pathway inhibitors in mouse peritoneal macrophage apoptosis infected with the Xinjiang strain of M. tuberculosis |
| Q37631384 | NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells |
| Q35998570 | NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains |
| Q33597837 | Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells |
| Q26863645 | Regulation of G Protein-Coupled Receptor Function by Na+/H+Exchange Regulatory Factors |
| Q55061344 | Regulation of β2-adrenergic receptor cell surface expression by interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL). |
| Q36808215 | SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells |
| Q36538416 | Temporal and spatial regulation of ezrin-radixin-moesin-binding phosphoprotein-50-kDa (EBP50) during embryo implantation in mouse uterus |
| Q39343398 | The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells |
| Q39181929 | Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadher in pathway in human hepatocellular cancer |
Search more.